Local Institution

Olsztyn 10-513

0 studies enrolling now · 7 studies all time

What they study most

Bladder Cancer, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus II, Hepatitis C Virus (HCV), Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction, Lung Cancer, Lung Cancer - Non Small Cell Squamous, Metastasis, Prostate Cancer, Small Cell Lung Cancer, Transitional Cell Carcinoma

Studies at this site

• Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C — Withdrawn before enrolling
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed